Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Lachance, Silvy  [Clear All Filters]
Journal Article
Claveau J-S, LeBlanc R, Ahmad I, Delisle J-S, Cohen S, Kiss T, Bambace NM, Bernard L, Lachance S, Roy DClaude, et al. Bortezomib maintenance after allogeneic transplantation in newly diagnosed myeloma patients results in decreased incidence and severity of chronic GVHD. Transplant Cell Ther. 2022.
Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle J-S, Fleury I, Kiss T, Mollica L, Roy D-C, et al. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients. Biol Blood Marrow Transplant. 2019.
Cohen S, Bambace N, Ahmad I, Roy J, Tang X, Zhang M-J, Burns LJ, Barabé F, Bernard L, Delisle J-S, et al. Improved Outcomes of UM171-Expanded Cord Blood Transplantation Compared with Other Graft Sources: Real-World Evidence. Blood Adv. 2023.
Claveau J-S, Cohen S, Ahmad I, Delisle J-S, Kiss T, Lachance S, Sauvageau G, Busque L, Brito R-M, Bambace N, et al. Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors. Eur J Haematol. 2020.
Dumont-Lagacé M, Li Q, Tanguay M, Chagraoui J, Kientega T, Cardin GB, Brasey A, Trofimov A, Carli C, Ahmad I, et al. UM171-expanded cord blood transplants support robust T cell reconstitution with low rates of severe infections. Biol Blood Marrow Transplant. 2020.